— Know what they know.
Not Investment Advice

VCYT NASDAQ

Veracyte, Inc.
1W: +16.2% 1M: +34.1% 3M: +26.8% YTD: +6.6% 1Y: +56.9% 3Y: +83.8% 5Y: +23.6%
$45.03
-0.16 (-0.35%)
After Hours: $46.95 (+1.92, +4.26%)
Weekly Expected Move ±13.5%
$28 $33 $38 $44 $49
NASDAQ · Healthcare · Biotechnology · Alpha Radar Strong Buy · Power 74 · $3.6B mcap · 79M float · 1.23% daily turnover · Short 69% of daily vol

Cash Flow Trends

Operating Cash Flow
$136M +81.5% ▲
Capital Expenditures
$10M +14.3% ▲
5Y CAGR: +27.8%
Free Cash Flow
$127M +98.5% ▲
Dividends Paid
$0 +0.0% ▲
Buybacks
$0 +0.0% ▲
Net Change in Cash
$124M +430.4% ▲

Cash Flow Composition

Year-over-Year Growth

View Full Cash Flow Statement
Line ItemFY2021FY2022FY2023FY2024FY2025
— Operating Activities —
Net Income-$76M-$37M-$74M$24M$66M
Depreciation & Amort.$20M$26M$27M$23M$21M
Stock-Based Comp.$23M$27M$33M$36M$44M
Change in Working Capital$4M-$16M-$4M-$21M-$2M
Other Non-Cash Items$4M$8M$66M$13M$8M
Operating Cash Flow-$32M$8M$44M$75M$136M
— Investing Activities —
Capital Expenditures-$5M-$9M-$10M-$11M-$10M
Acquisitions (Net)-$737M$0$0$5M-$3M
Investment Purchases$162M-$34M-$20M-$50M-$150M
Investment Sales$3M$13M$45M$0$153M
Other Investing-$162M$0$0$0$0
Investing Cash Flow-$739M-$29M$15M-$56M-$9M
— Financing Activities —
Net Debt Issuance$0-$1M$0$0$0
Stock Repurchased$0$0$0$0$0
Dividends Paid$0$0$0$0$0
Other Financing$2M$5M$3M-$15M-$18M
Financing Cash Flow$596M$3M$3M$5M-$4M
Net Change in Cash-$176M-$19M$62M$23M$124M
Cash End of Period$174M$155M$217M$241M$364M
Free Cash Flow-$37M-$1M$34M$64M$127M

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms